Jack Meehan
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
131
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $234 → $249 | $227.10 | +9.64% | 11 | Oct 25, 2024 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $136.87 | -8.67% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $387.21 | -25.62% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $22.31 | +47.92% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $149.76 | +117.01% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $17.26 | +10.08% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $155.29 | -36.25% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $220.40 | -18.33% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $17.99 | -44.41% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $209.16 | -20.63% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $82.33 | -47.77% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $180.96 | -14.90% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $368.42 | +16.71% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $334.85 | +28.42% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $39.10 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $59.29 | -19.04% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,342.09 | -49.33% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $104.17 | -71.20% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $557.92 | -46.23% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.75 | +2,192.26% | 1 | Dec 11, 2017 |
Labcorp Holdings
Oct 25, 2024
Maintains: Equal-Weight
Price Target: $234 → $249
Current: $227.10
Upside: +9.64%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $136.87
Upside: -8.67%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $387.21
Upside: -25.62%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $22.31
Upside: +47.92%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $149.76
Upside: +117.01%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $17.26
Upside: +10.08%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $155.29
Upside: -36.25%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $220.40
Upside: -18.33%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $17.99
Upside: -44.41%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $209.16
Upside: -20.63%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $82.33
Upside: -47.77%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $180.96
Upside: -14.90%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $368.42
Upside: +16.71%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $334.85
Upside: +28.42%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $39.10
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $59.29
Upside: -19.04%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,342.09
Upside: -49.33%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $104.17
Upside: -71.20%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $557.92
Upside: -46.23%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.75
Upside: +2,192.26%